Deep brain stimulation and levodopa affect gait variability in Parkinson disease differently
Background Both dopaminergic medication and subthalamic nucleus (STN) deep brain stimulation (DBS) can improve the amplitude and speed of gait in Parkinson disease (PD), but relatively little is known about their comparative effects on gait variability. Gait irregularity has been linked to the degen...
Main Authors: | Su, ZH, Patel, S, Gavine, B, Buchanan, T, Bogdanovic, M, Sarangmat, N, Green, AL, Bloem, BR, FitzGerald, JJ, Antoniades, CA |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
The effect of levodopa on saccades – Oxford Quantification in Parkinsonism study
by: Lu, Z, et al.
Published: (2019) -
Parkinson's disease deficits in time perception to auditory as well as visual stimuli - A large online study
by: Su, ZH, et al.
Published: (2022) -
Seeing is believing: photon counting computed tomography clearly images directional deep brain stimulation lead segments and markers after implantation
by: Manfield, J, et al.
Published: (2023) -
Oculomotor deficits in Parkinson's disease: Increasing sensitivity using multivariate approaches
by: Bredemeyer, O, et al.
Published: (2022) -
Using saccades as an early test of levodopa treatment in Parkinson's Disease
by: Lu, Z, et al.
Published: (2018)